Skip to main content
Caplight Logo









CELLmeric Limited

CELLmeric Limited

Private
Hong KongHealthcare & Life Scienceshttps://cellmeric.com/

Last Round

Series A

Dec 5, 2025

Total Funding Raised

$20M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CELLmeric Limited is a biotechnology company that provides a virus-free gene delivery system for CAR-T cell engineering to make cancer therapies safer and more affordable.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

non-viral gene deliverygene delivery platformcell therapy manufacturingCAR-T cell manufacturingcell engineeringCAR-TCGT manufacturinggene editingimmunotherapyNK cell manufacturingelectroporationbiotech licensinglife science toolsGMP manufacturingstable cell line generation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CELLmeric Limited Comparables

Compare CELLmeric Limited with similar companies based on industry and business-model similarity.

CELLmeric Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Indee Labs
83%
Avectas
81%
Kytopen
81%

CELLmeric Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 5, 2025
Pre SeedDec 5, 2025

CELLmeric Limited Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 5, 2025

    $20M raised from Hong Kong Science and Technology Park and others.

  • Dec 5, 2025

    $23M round completed.

CELLmeric Limited Filings

Explore SEC and related filing metadata, where available.

CELLmeric Limited filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CELLmeric Limited's valuation, stock price, and market status.

Is CELLmeric Limited a public or private company?

CELLmeric Limited is a private company.

What is the current stock price of CELLmeric Limited?

CELLmeric Limited is a private company with no public stock price. No recent secondary market data is available.

How much is CELLmeric Limited worth (valuation)?

Valuation information for CELLmeric Limited is not publicly available.

Can I buy CELLmeric Limited stock?

CELLmeric Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CELLmeric Limited's last funding round?

CELLmeric Limited's most recent funding round was Series A on December 5, 2025.

Who are the main investors in CELLmeric Limited?

Key investors in CELLmeric Limited include The Chinese University of Hong Kong, Faculty of Medicine, Hong Kong Science and Technology Park, Innovation and Technology Commission.

Will CELLmeric Limited IPO soon?

No public IPO plans have been announced for CELLmeric Limited.

How can I track CELLmeric Limited secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CELLmeric Limited's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHong Kong
Year Founded2025
Last FundingDec 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?